Skip to main content

Table 1 MSQoL-54 Physical and Mental scores in non-persistent, persistent, persistent non-adherent, and persistent adherent patients at baseline

From: Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)

  MSQoL-54 Physical
Non-persistent (n = 70) Persistent (n = 119) Persistent non-adherent (n = 18) Persistent adherent (n = 101)
Mean (SD)
(min.-max.)
49.5 (17.6)*
(13.0-91.5)
58.1 (16.9)*
(21.3-94.8)
55.5 (15.2)
(29.6-79.4)
58.6 (17.2)
(21.3-94.8)
  MSQoL-54 Mental
  Non-persistent (n = 74) Persistent (n = 123) Persistent non-adherent (n = 19) Persistent adherent (n = 104)
Mean (SD)
(min.-max.)
55.9 (20.4)#
(21.2-94.4)
63.8 (16.8)#
(19.8-90.6)
61.7 (14.9)
(33.5-83.4)
64.2 (17.2)
(19.8-90.6)
  1. MSQoL-54, Multiple Sclerosis Quality of Life-54, min. minimum; max. maximum
  2. *P = 0.001; # P = 0.003